US Broker Ratings

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Examining a 67.60% Potential Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) presents an intriguing opportunity for investors within the healthcare sector, particularly those focused on the burgeoning field of medical devices. With a market capitalization of..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating the Upside Potential in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, focuses on advancing life science technologies through its innovative platforms. With a market capitalization of $1.47 billion, 10x..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 53.90% Upside Potential

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the healthcare sector, is capturing investor attention with its potential upside of 53.90%, based on current analyst ratings. Operating in the diagnostics..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: A Look at a 101% Potential Upside for Savvy Investors

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its substantial potential upside. The company, headquartered in..

Privia Health Group, Inc. (PRVA) Investor Outlook: Eyeing a 42% Potential Upside with Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA) stands out in the healthcare sector as a dynamic player in the health information services industry. With its focus on enabling physician practices through..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Biotechnology Innovator with 44.89% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a pivotal player in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug discovery and a robust pipeline of..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 164% Potential Upside in Biotech

Immunovant, Inc. (NASDAQ: IMVT) has been capturing investor attention in the biotechnology sector with a staggering potential upside of 164.22%. Specializing in developing monoclonal antibodies for autoimmune diseases, Immunovant is..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A Potential 134% Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company at the forefront of addressing rare kidney and metabolic diseases, is capturing investor attention with its notable growth potential. With a current..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring an 86% Potential Upside in the Healthcare Sector

Investors with a keen eye on the healthcare sector might find Kestra Medical Technologies, Ltd (KMTS) an intriguing opportunity. Despite recent fluctuations, the company is demonstrating remarkable potential, especially with..

SS Innovations International (SSII) Stock Analysis: Exploring Growth Potential Amidst Strong Revenue Momentum

SS Innovations International, Inc. (SSII), headquartered in Gurugram, India, is carving a niche in the healthcare sector as a formidable player in the medical devices industry. With a market capitalization..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 36% Potential Upside Amid Promising CNS Innovations

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, is garnering attention from investors for its significant potential upside and strategic focus on central nervous system (CNS)..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 33.89% Potential Upside and Analyst Consensus

LivaNova PLC (NASDAQ: LIVN), a key player in the medical devices industry, has been capturing the attention of investors with its promising growth prospects and significant potential upside. Headquartered in..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Report: A 41.73% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a noteworthy player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is capturing investor attention with its significant potential upside...

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 30.92% Upside Potential in the Healthcare Sector

For investors keen on the healthcare sector, particularly within the niche of non-opioid pain management, Pacira BioSciences, Inc. (NASDAQ: PCRX) presents an intriguing opportunity. As a key player in the..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A Strong Buy with a 141% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is garnering significant attention in the biotechnology sector, offering promising opportunities for investors with its focus on developing treatments for serious and rare diseases. Known..

Phreesia, Inc. (PHR) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Phreesia, Inc. (NYSE: PHR) is carving a niche for itself in the healthcare industry, leveraging its integrated SaaS-based software and payment platform to transform patient engagement and streamline healthcare operations...

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling a Potential 125.88% Upside in the Biotech Arena

For investors with an eye on the biotechnology sector, Denali Therapeutics Inc. (NASDAQ: DNLI) offers a compelling opportunity. With its focus on developing treatments for complex neurodegenerative and lysosomal storage..

Sotera Health Company (SHC) Stock Analysis: Exploring a 27% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare sector, has caught the attention of investors with its promising potential upside of 27.19%. As a leader in sterilization,..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Healthcare Play with 43% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS) stands out as a compelling investment opportunity within the healthcare sector, particularly in the burgeoning field of cell and gene therapy (CGT). The company, with..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Eyeing a 34.94% Upside with Innovative Urology Solutions

Investors with an eye on the healthcare sector should take a closer look at PROCEPT BioRobotics Corporation (NASDAQ: PRCT), an innovative player in the medical devices industry. Specializing in surgical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds